Hai dimenticato la password?
|
Registrati
E-mail
Password
Resta Collegato
Cerca per parole nell'archivio:
In archivio:
N° Relazioni:
792
N° Accessi Relaz.:
155382
home
|
progetto
|
chi siamo
|
servizi
|
contatti
|
note legali
11th WORLD CONGRESS OF GYNECOLOGICAL ENDOCRINOLOGY
26/02/2004 - 29/02/2004
Programma Evento
Info
Mostra tutti
|
Mostra contenuti EasyRec
26/02/2004
AUDITORIUM
08:00 - 10:00
OPENING LECTURE
C. Christiansen
The management of osteporosis
10:20 - 12:20
SERMS: A MULTIPURPOSE TOOL IN THE MENAGEMENT OF MENOPAUSE
M. Gambacciani
Raloxifene: a drug for bone quality and fracture prevention
A.M. Paoletti
Raloxifene: a drug for uterus and genital tract therapy
P. Neven
Raloxifene: effects on the breast
J. Calaf
SERMs: a multipurpose tool in the management of osteoporosis
D. Agnusdei
The future for raloxifene: a firework
12:30 - 13:00
PLENARY LECTURE
M.L. Brandi
Estrogen receptor polymorphisms and women's health ande desease
14:00 - 16:00
DROSPIRENONE: MORE THAN A PROGESTOGEN - SPONSORED BY SCHERING
H. Rozenbaum
Introduction
W. Oelkers
Drospirenone: progestogen for contraception and HRT
G.A. MacGregor
Aldosterone antagonist effects of drospirenone
JM. Foidart
Benefits of drospirenone on water retention
C. Christiansen
Effects of drospirenone/estrogen combinations on bone metabolism
16:10 - 16:40
PLENARY LECTURE
P.N. Barri
Multiple pregnancies: an inevitable consequence of ART?
17:00 - 19:00
HRT AND FEMALE HEALTH: FROM RANDOMIZED CLINICAL TRIALS TO CLINICAL PRACTICE - SPONSORED BY ROTTAPHARM
C. Stevenson J
HRT cardiovascular effects are dependent on regimen used (S1)
P. Maki
Hormone therapy and cognitive function: is there a critical period for neuroprotection?
P. Sismondi
Breast cancer and colon cancer
H. Rozenbaum
Quality of life
L. Speroff
A clinician's response tyo the WHI (S3)
P-AFFARI
10:20 - 12:00
AUTOCRINE, PARACRINE AND ENDOCRINE MECHANISMS OF OOCYTE AND EARLY EMBRYO DEVELOPMENT
PG. Artini
Vascular endothelial growth factor in embryo endometrial interaction
Z. Ben-Rafael
The inflammatory response during COH
12:30 - 13:00
PLENERY LECTURE
PL. Schenker
Hyperprolactinemia and human reproduction
14:00 - 16:00
STEROIDS IN BRAIN REMODELLING AND PROTECTION
E.E. Baulieu
Steroids in neurocells. Remodelling and function
F. Naftolin
Estrogen, synaptic plasticity and hypothalamic reproductive aging
R. Diaz Brinton
Progestin regulation of estrogen signaling in brain: crucial issues for hormone replacement therapy
M. Serio
Hormonal control of antiapoptotic genes in human neurons
16:10 - 16:40
PLENARY LECTURE
Benninck PL Coellingh
Esterol, the forgotten human fetal estrogen: an estrogen antagonist for the breast
17:00 - 19:00
PRE-TERM LABOUR AND DELIVERY
CJ. Lockwood
Thrombin induces decidual protease and cyotkine expression in the pathogenesis of preterm membrane rupture associated with abruption
T. Laudanski
Preterm labour: role of the myometrium
P. Florio
Predective factors of preterm labour and delivery
M. Akerlund
Preterm labour and delevery - therapy: the future
HJA Carp
Role of thrombophilias in pregnancy and recurrent pregnancy loss
27/02/2004
AUDITORIUM
08:30 - 10:00
NEW STRATEGIES FOR POSTMENOPAUSAL OSTEOPOROSIS MANAGEMENT
G.B. Serra
Recent advances for postmenopausal osteoporosis management
S. Adami
Risedronate and osteoporosis treatment
M. Gambacciani
Hormone replacement therapy for the prevention of osteoporosis in postmenopausal women
10:20 - 12:20
FROM FETAL DEVELOPMENT TO MENOPAUSE - SPONSORED BY SOLVAY
P.V. Nathanielsz
The influence of early development: from fetus to menopause
F. Petraglia
Endocrine and paracrine control of progesterone secretion during pregnancy
P. Van de Weijer
Hormones and the patient and the media restoration of trust in our day-to-day practice (S14)
13:10 - 15:10
MILLION WOMEN'S STUDY
R. Gray
HRT and breast cancer - a meta-analysis of clinical trials and epidemiological studies
J. Fiorica
The role of progestins on the breast; information derived from the million women's study
S. Shapiro
The million women's study. Potential biases do not allow a uncritical acceptance of the data
M. Whitehead
The million women's study
15:10 - 17:10
MAMMOGRAPHIC DENSITY AND ITS IMPLICATIONS FOR THE INDIVIDUAL WOMAN'S HEALTH - SUPPORTED BY AN UNRESTRICTED GRANT FROM ORGANON
R. Santen
Breast cancer and mammographic density
J. Eden
The need for tissue selective menopausal agents
M.C. Pike
The clinical view
M.J. Yaffe
The radiological view
17:30 - 19:30
ORAL CONTRACEPTION: THE BEST CHOICE FOR FERTILE WOMAN - SPONSORED BY WYETH
J. Huber
Sigmund Freud, Gustav Mahler, the pill and levonorgestrel
Martinez-Perez
Loette: "evidence-based medicine in OC" the Spanish experience
A. Cagnacci
Modern OC: the VTE controversy (VTE EMEA recommendation)
M. Primiero
Worldwide Loette clinical experience and reasons for further regimens (continuos use LNG/EE)
P-AFFARI
10:20 - 12:20
STEROID RECEPTORS SIGNALING: MOLECULAR BASIS
T. Maruo
Progesterone and SPRM in uterine leiomyoma growth and apoptosis
T. Simoncini
New mechanisms for steroid hormone signalling
L. Devoto
Steroidogenic acute regulatory protein (StAR) in the human corpus luteum
15:10 - 17:10
AMENORRHOEA: FROM DIAGNOSIS TO TREATMENT
S.L. Berga
Neuroendocrine aspects of amenorrhea
M. Warren
Amenorrhoea: from diagnosis to treatment
B. Mecekalski
Functional hypothalamic amenorrhoea
17:30 - 19:30
ENDOCRINE ASPECTS OF ASSISTED REPRODUCTION
M. Szamatowicz
Controlled ovarian hyperstimulation - the important step in ART. How to choose the best way of stimulation?
BC. Tarlatzis
Ovarian stimulation and carcinogeneity
PC. Ho
Oestradiol levels and endometrial receptivity
J. Dor
Poor responders: can we improve the outcome?
28/02/2004
AUDITORIUM
08:30 - 10:00
METFORMING: A NEW CHALLENGE FOR POLYCYSTIC OVARY SINDROME - SPONSORED BY GUIDOTTI
A. Lanzone
Glucose metabolism, insulin and ovarian androgens: what's the linkage
A.M. Fulghesu
Adolescence and hyperinsulinemia: it is always the first step towords PCOS?
A.D. Genazzani
Insulin-sensitizer metformin as direct/indirect modulator of the neuroendocrine control of gonadotropin secretion in hyperandrogenic women
J.E. Nestler
Rationale and strategies for the use of metoformin to treat infertility in the polycystic ovary syndrome
10:10 - 10:40
PLENARY LECTURE
P. Kenemans
Hormone replacement before and after breast cancer
14:00 - 14:30
PLENERY LECTURE - SPONSORED BY PFIZER
S. Caruso
New prospectives in the managment of female sexual dysfunction: from pathophisiology to therapies
14:40 - 16:10
FROM OVULATION INDUCTION TO PREGNANCY MAINTENANCE - SPONSORED BY IBSA
L.G. Westergard
Follicular fluid and serum levels of steroids and gonadotrophins in ART: relationships to st imulation protol and reproductive outcome
J.G. Grudzinska
FSH: its measurement and administration in ART
G.F. Scarselli
Progesterone and implantation
16:20 - 16:50
PLENARY LECTURE
G. Creatsas
Disfunctional uterine bleeding during adolescence
P-AFFARI
08:30 - 10:00
LA VIA TRANSDERMICA REINVENTA LA CONTRACCEZIONE: GINECOLOGI E DONNE A CONFRONTO - SPONSORED BY JANSSEN-CILAG
Tavola rotonda
(J. Baldaro Verde, V. Bruni, A.R. Genazzani, G.B. Melis)
11:00 - 13:00
ENDOMETRIOSIS
T.M. D' Hooghe
PAthophysiology of endometriosis
V. Cela
Endometriosis: diagnosis
A.E. Schindler
Medical treatment of endometriosis
A. Luciano
Role of GnRH-a in endometriosis
A. Wattiez
Surgical treatment
14:00 - 14:30
PLENARY LECTURE
D. Purdie
The oestrogens: pluripotent and polyvalent
14:40 - 16:10
PHYTOHORMONES: NEW SCIENTIFIC INSIGHTS IN EFFICACY AND SAFETY FOR WOMEN - SPONSORED BY NAMED
M. Imhof
Do Phytohormones cause changes in genome activity?
J. Huber
Nutrigenomics and Phytosteroids
T. Simoncini
Vascular actions of red clover extracts
16:20 - 16:50
PLENARY LECTURE - SPONSORED BY SERVIER
P. Kenemans
Why pulsed estrogen exposure results in better target tissue selectivity: a hypothesis (PL10)
17:20 - 19:20
GENOMICS AND PROTEOMICS IN GYNECOLOGICAL CANCERS
W. Wu
Genomics and proteomics: new techniques in cancer research
P.M. Comoglio
Post-genomic research unveils the genetic basis of invasive metastatic program
M.B. Daly
Proteomic approaches to tumor markers discovery in ovarian cancer
A. Arcangeli
VERDE
14:40 - 16:40
HORMONES AND CANCER
R.J. Santen
Role of estrogenes in the development of breast cancer
J. Prat
Hyperplasia and carcinoma of the endometrium
A. Gadducci
Sex steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological experimental data
F. Al-Azzawi
Colon cancer
29/02/2004
AUDITORIUM
08:30 - 10:30
AGE-RELATED INFERTILITY AND OVARIAN FAILURE
V. Bruni
Gonadal dysgenesis, from diagnosis to treatment
J. Studd
Premature menopause - treatment
A. Lewin
Physiopathology and treatment of age related female reproductive failure
A. Vujovic
COLIA 1 gene polymorphism ovarian failure
11:00 - 13:00
THE POSTMENOPAUSAL WOMAN'S RISK: THE THERAPEUTIC DILEMMA
MJ. Mooren Van der
HRT and cardiovascular health in PMW
A.R. Genazzani
HRT and the central nervous system in PMW
O. Ylikorkala
New SERMs, can they replace HRT?
P. Weijer Van der
Seven years is a long time! The Heikkinen study: long term adherece to continuous combined hormone therapy
P-AFFARI
08:30 - 10:30
ENDOCRINE AND METABOLIC DISEASES: IMPACT ON WOMEN'S HEALTH
S. Skouby
Diabetes Mellitis
A. Pines
Cardiovascular disease and women's health
G.P. Chrousos
Adrenal disorders
A. Pinchera
Thyroid disease and pregnancy
11:00 - 13:00
POLYCYSTIC OVARI SYNDROME
J.F. Strauss III
PCOS: molecular clues to pathophysiology
A. Dunaif
Genes and enviroment in the pathogenesis of PCOS
A. Lanzone
Evaluation of clinical, biochemical and ultrasound parameters for the polycystic ovarian syndrome's diagnosis
A. Milewicz
Plasma adioponectin and resistin levels in obese PCO women: the effect of metoformin treatment
J.E. Nestler
Polycystic ovary syndrome (PCOS) and insulin resistance: implication for treatment of infertility
home
|
progetto
|
chi siamo
|
servizi
|
contatti
|
note legali
Tuttocongressi ©1995 - 2024 | Via Dei Perfetti Ricasoli, 94-96 - 50127 Firenze | P.Iva 03755090481